NCT05428371View on ClinicalTrials.gov

Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features

Not yet recruitingOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2027

Conditions
Thyroid NoduleThyroid Cancer
Interventions
DIAGNOSTIC_TEST

Multiomic analyses of blood and surgical specimens

"The following items will be evaluated:~* cell free dna length and integrity~* presence or absence of SNPs in cfDNA and in DNA extracted from surgical samples~* qualitative and quantitative evaluation of serum and surgical specimens proteome (proteomics)"

Trial Locations (1)

09100

AOU Cagliari, Cagliari

All Listed Sponsors
collaborator

Prof. Pietro Giorgio Calò

UNKNOWN

collaborator

Dott. Gian Luigi Canu

UNKNOWN

lead

University of Cagliari

OTHER

NCT05428371 - Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features | Biotech Hunter | Biotech Hunter